Baseline and postcaptopril renal blood flow measurements in hypertensives suspected of renal artery stenosis.
Renal blood flow (RBF) measurements using first-pass radionuclide angiography with DTPA, a glomerularly filtered agent, failed to show significant differences between normal and stenotic kidneys. Since MAG3 is an ideal agent for the study of RBF, this agent might be an attractive alternative tracer to detect differences in RBF.


METHODS
An angiographically controlled prospective study was performed in 48 hypertensive patients, in whom a diagnosis of renovascular hypertension was suspected on clinical grounds. The study was done to determine whether RBF measurements using first-pass radionuclide angiography with 99mTc-MAG3 could be helpful in the diagnostic work-up of the patients. Additionally, the study was done before and after ACE-inhibition.


RESULTS
On renal angiography, 29 patients showed to have normal renal arteries (50 patients had normal kidneys and 8 patients had small kidneys). Nineteen patients had renal artery stenosis (13 uni- and 6 bilateral disease). In the patients with normal kidneys, the mean value of RBF measurements ranged from 10.5% to 10.9% of cardiac output. Only small stenotic and small kidneys with normal renal arteries showed a significant reduced baseline RBF as compared with normal kidneys (both p < 0.05); this difference disappeared after ACE-inhibition only for the small kidneys with normal renal arteries. In patients with stenosed kidneys, RBF tended to be reduced both at baseline and after captopril, but the differences with normal kidneys were not statistically significant. After ACE-inhibition RBF increased in the majority of kidneys, but postcaptopril RBF data did not differ significantly from those at baseline.


CONCLUSIONS
RBF measurements using first-pass radionuclide angiography with 99mTc-MAG3, either before or after ACE-inhibition, cannot reliably discriminate between patients with essential hypertension and patients with renal artery stenosis.
Schreij
G
G
Department of Internal Medicine, University Hospital Maastricht, The Netherlands.
van Es
P N
PN
van Kroonenburgh
M J
MJ
Kemerink
G J
GJ
Heidendal
G A
GA
de Leeuw
P W
PW
D002216:Captopril; D006801:Humans; D006973:Hypertension / Q000000981:diagnostic imaging / Q000503:physiopathology; D006978:Hypertension, Renovascular / Q000209:etiology*; D008875:Middle Aged; D011446:Prospective Studies; D011875:Radionuclide Angiography; D012077:Renal Artery / Q000000981:diagnostic imaging; D012078:Renal Artery Obstruction / Q000150:complications / Q000000981:diagnostic imaging* / Q000503:physiopathology; D012079:Renal Circulation / Q000187:drug effects*; D017263:Technetium Tc 99m Mertiatide
D017263:Technetium Tc 99m Mertiatide; D002216:Captopril